There you go again, parroting stockbrokers and Oncosil.
"The data data showed the devise is clinically safe and provides significant benefits with almost 25% resection rate and significant tumour volume reduction in almost all patients."
This is where I believe your confusion lies. The data did NOT show any of this about the oncosil device. It's time you started parroting scientists and academics.
OSL Price at posting:
5.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)